IRCT20240501061620N1Not yet recruitingPhase 3
Evaluation of the effect of curcumin in the prevention of vancomycin-induced nephrotoxicity in patients hospitalized in the intensive care unit of Kosar Hospital, Semnan: a randomized, double-blinded, placebo-controlled clinical trial
Semnan University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 70
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 65 years (—)
- Sex
- All
Inclusion Criteria
- •Patients aged 18-65, receiving vancomycin
- •Creatinine clearance > 45 ml/min
Exclusion Criteria
- •Proteinuria and/or hematuria, acute kidney injury or any underlying renal disorder
- •Sever liver disease
- •Sever and active bleeding
- •Receiving any other nephrotoxic drug
- •Receiving anticoagulant drugs at therapeutic doses or receiving warfarin
- •Receiving antioxidant supplements
Investigators
Similar Trials
Recruiting
Phase 3
Investigation of the Effect of Curcumin in preventing complications of chemotherapyIRCT20190224042818N1Mashhad University of Medical Sciences40
Completed
Phase 3
Evaluation of the effectiveness of curcumin in the prevention of contrast induced nephropathy in following coronary AngiographyContrast induced nephropathy in following coronary angiography.Nephrotic syndromeIRCT20190911044744N4Yazd University of Medical Sciences60
Completed
Phase 3
Efficacy and mechanism of curcumin in prevention and treatment of diabetes, liver cirrhosis from nonalcoholic fatty liver disease (NAFLD), and osteoporosis in the patients with type 2 diabetescurcuminoids extracttype 2 diabetesinsulin resistanceobesityfatty liverosteoporosiscurcuminoids extracttype 2 diabetesfatty liverinsulin resistanceobesityosteoporosisTCTR20140303003Thailand Research Fund296
Recruiting
Phase 1
Evaluation of the effectiveness of Curcumin in the improving patients with autoimmune hepatitisAutoimmune hepatitisIRCT20221112056476N1Zahedan University of Medical Sciences68
Recruiting
Phase 2
Effect of curcumin in treatment of respiratory syndrome of coronaCovid-19.Covid-19 diseaseU07.1IRCT20200418047119N1Kermanshah University of Medical Sciences42